(DBD) Diebold Nixdorf - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 2.810m USD | Total Return: 63.2% in 12m
Avg Turnover: 21.9M
Qual. Beats: 0
Rev. Trend: 42.4%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Diebold Nixdorf, Incorporated (NYSE: DBD) specializes in automation and digitization solutions for the global banking and retail sectors. The company’s Banking segment focuses on the manufacturing and servicing of automated teller machines (ATMs) and cash recycling technology, while the Retail segment provides electronic point-of-sale (EPOS) systems and self-checkout kiosks. Its business model integrates hardware sales with long-term service contracts and proprietary software platforms, such as DN Vynamic, to provide data analytics and remote monitoring.
The self-service hardware market is increasingly driven by the transition to cash recycling, which reduces operational costs by reusing deposited banknotes for withdrawals. Additionally, the retail sectors shift toward modular EPOS systems allows for greater flexibility in high-volume environments like grocery and fuel stations. For a deeper look into the companys fundamental performance, you can explore the metrics available on ValueRay.
Headquartered in North Canton, Ohio, and founded in 1859, the firm operates as a critical infrastructure provider for financial institutions and merchants. Its service-led approach utilizes AI-driven predictive diagnostics via the Allconnect data engine to minimize device downtime and optimize cash management cycles.
- Global demand for cash recycling technology drives Banking segment revenue growth
- High interest rates increase debt servicing costs following financial restructuring
- Retail automation adoption accelerates demand for self-checkout and POS systems
- Supply chain stability impacts delivery timelines for integrated hardware solutions
- Service contract renewals provide high-margin recurring revenue and cash flow stability
| Net Income: 107.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 1.93 > 1.0 |
| NWC/Revenue: 10.27% < 20% (prev 12.00%; Δ -1.73% < -1%) |
| CFO/TA 0.08 > 3% & CFO 316.7m > Net Income 107.9m |
| Net Debt (851.9m) to EBITDA (456.1m): 1.87 < 3 |
| Current Ratio: 1.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.7m) vs 12m ago -5.05% < -2% |
| Gross Margin: 26.33% > 18% (prev 25.14%; Δ 1.19% > 0.5%) |
| Asset Turnover: 103.5% > 50% (prev 102.0%; Δ 1.49% > 0%) |
| Interest Coverage Ratio: 3.78 > 6 (EBIT TTM 331.1m / Interest Expense TTM 87.5m) |
| A: 0.10 (Total Current Assets 1.80b - Total Current Liabilities 1.40b) / Total Assets 3.83b |
| B: 0.03 (Retained Earnings 96.9m / Total Assets 3.83b) |
| C: 0.09 (EBIT TTM 331.1m / Avg Total Assets 3.73b) |
| D: 0.36 (Book Value of Equity 1.02b / Total Liabilities 2.80b) |
| Altman-Z'' = 1.74 = BBB |
| DSRI: 0.95 (Receivables 597.0m/602.6m, Revenue 3.86b/3.70b) |
| GMI: 0.95 (GM 25.14% / 26.33%) |
| AQI: 1.00 (AQ_t 0.45 / AQ_t-1 0.45) |
| SGI: 1.04 (Revenue 3.86b / 3.70b) |
| TATA: -0.05 (NI 107.9m - CFO 316.7m) / TA 3.83b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of June 07, 2026, the stock is trading at USD 81.14 with a total of 292,524 shares traded.
Over the past week, the price has changed by +0.00%,
over one month by +4.66%,
over three months by +3.32% and
over the past year by +63.23%.
Diebold Nixdorf has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy DBD.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 98.3 | 21.2% |
P/E Trailing = 27.9793
P/E Forward = 12.1655
P/S = 0.7286
P/B = 2.7468
Revenue TTM = 3.86b USD
EBIT TTM = 331.1m USD
EBITDA TTM = 456.1m USD
Long Term Debt = 939.4m USD (from longTermDebt, last quarter)
Short Term Debt = 55.4m USD (from shortTermDebt, last quarter)
Debt = 1.23b USD (from shortLongTermDebtTotal, last quarter) + Leases 131.9m
Net Debt = 851.9m USD (calculated: Debt 1.23b - CCE 373.6m)
Enterprise Value = 3.66b USD (2.81b + Debt 1.23b - CCE 373.6m)
Interest Coverage Ratio = 3.78 (Ebit TTM 331.1m / Interest Expense TTM 87.5m)
EV/FCF = 13.77x (Enterprise Value 3.66b / FCF TTM 266.0m)
FCF Yield = 7.26% (FCF TTM 266.0m / Enterprise Value 3.66b)
FCF Margin = 6.90% (FCF TTM 266.0m / Revenue TTM 3.86b)
Net Margin = 2.80% (Net Income TTM 107.9m / Revenue TTM 3.86b)
Gross Margin = 26.33% ((Revenue TTM 3.86b - Cost of Revenue TTM 2.84b) / Revenue TTM)
Gross Margin QoQ = 25.25% (prev 27.14%)
Tobins Q-Ratio = 0.96 (Enterprise Value 3.66b / Total Assets 3.83b)
Interest Expense / Debt = 7.14% (Interest Expense 87.5m / Debt 1.23b)
Taxrate = 22.47% (32.0m / 142.4m)
NOPAT = 256.7m (EBIT 331.1m * (1 - 22.47%))
Current Ratio = 1.28 (Total Current Assets 1.80b / Total Current Liabilities 1.40b)
Debt / Equity = 1.20 (Debt 1.23b / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 1.87 (Net Debt 851.9m / EBITDA 456.1m)
Debt / FCF = 3.20 (Net Debt 851.9m / FCF TTM 266.0m)
Total Stockholder Equity = 1.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.89% (Net Income 107.9m / Total Assets 3.83b)
RoE = 9.97% (Net Income TTM 107.9m / Total Stockholder Equity 1.08b)
RoCE = 16.38% (EBIT 331.1m / Capital Employed (Equity 1.08b + L.T.Debt 939.4m))
RoIC = 11.22% (NOPAT 256.7m / Invested Capital 2.29b)
WACC = 7.48% (E(2.81b)/V(4.04b) * Re(8.33%) + D(1.23b)/V(4.04b) * Rd(7.14%) * (1-Tc(0.22)))
Discount Rate = 8.33% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.70 | Cagr: -2.28%
[DCF] Terminal Value 77.97% ; FCFF base≈232.3m ; Y1≈266.3m ; Y5≈391.9m
[DCF] Fair Price = 145.7 (EV 5.90b - Net Debt 851.9m = Equity 5.05b / Shares 34.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.08 | # QB: 0
Revenue Correlation: 42.38 | Revenue CAGR: 1.05% | SUE: 0.95 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.10 | Chg30d=-3.50% | Revisions=+0% | Analysts=3
EPS next Quarter (2026-09-30): EPS=1.45 | Chg30d=+2.11% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=5.49 | Chg30d=+0.06% | Revisions=+0% | GrowthEPS=+16.1% | GrowthRev=+2.8%
EPS next Year (2027-12-31): EPS=6.79 | Chg30d=+1.14% | Revisions=+0% | GrowthEPS=+23.7% | GrowthRev=+3.2%
[Analyst] Revisions Ratio: +0%